JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Clinical trials for JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) explained in plain language.

Never miss a new study

Get alerted when new JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) trials appear

Sign up with your email to follow new studies for JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

One-Shot cell therapy aims to reset immune system in devastating muscle diseases

Disease control Recruiting now

This study is testing a single dose of an experimental cell therapy called CABA-201 for adults and children with active autoimmune muscle diseases, like dermatomyositis. The therapy uses the patient's own modified immune cells (CAR T-cells) to target and remove harmful B cells th…

Matched conditions: JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control

Last updated Apr 04, 2026 00:36 UTC

JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Get alerted when new JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) trials appear

One-Shot cell therapy aims to reset immune system in devastating muscle diseases